These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 7633420)
1. Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA). Jin H; Webster AD; Vihinen M; Sideras P; Vorechovsky I; Hammarstróm L; Bernatowska-Matuszkiewicz E; Smith CI; Bobrow M; Vetrie D Hum Mol Genet; 1995 Apr; 4(4):693-700. PubMed ID: 7633420 [TBL] [Abstract][Full Text] [Related]
2. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia. Vorechovský I; Vihinen M; de Saint Basile G; Honsová S; Hammarström L; Müller S; Nilsson L; Fischer A; Smith CI Hum Mol Genet; 1995 Jan; 4(1):51-8. PubMed ID: 7711734 [TBL] [Abstract][Full Text] [Related]
3. Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia. Brooimans RA; van den Berg AJ; Rijkers GT; Sanders LA; van Amstel JK; Tilanus MG; Grubben MJ; Zegers BJ J Med Genet; 1997 Jun; 34(6):484-8. PubMed ID: 9192269 [TBL] [Abstract][Full Text] [Related]
4. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA). Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238 [TBL] [Abstract][Full Text] [Related]
5. An exon-skipping mutation in the btk gene of a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency. Duriez B; Duquesnoy P; Dastot F; Bougnères P; Amselem S; Goossens M FEBS Lett; 1994 Jun; 346(2-3):165-70. PubMed ID: 8013627 [TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice. de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018 [TBL] [Abstract][Full Text] [Related]
7. Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece. Speletas M; Kanariou M; Kanakoudi-Tsakalidou F; Papadopoulou-Alataki E; Arvanitidis K; Pardali E; Constantopoulos A; Kartalis G; Vihinen M; Sideras P; Ritis K Scand J Immunol; 2001 Sep; 54(3):321-7. PubMed ID: 11555397 [TBL] [Abstract][Full Text] [Related]
8. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course. Holinski-Feder E; Weiss M; Brandau O; Jedele KB; Nore B; Bäckesjö CM; Vihinen M; Hubbard SR; Belohradsky BH; Smith CI; Meindl A Pediatrics; 1998 Feb; 101(2):276-84. PubMed ID: 9445504 [TBL] [Abstract][Full Text] [Related]
9. Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia. Saha BK; Curtis SK; Vogler LB; Vihinen M Mol Med; 1997 Jul; 3(7):477-85. PubMed ID: 9260159 [TBL] [Abstract][Full Text] [Related]
10. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase. Conley ME; Fitch-Hilgenberg ME; Cleveland JL; Parolini O; Rohrer J Hum Mol Genet; 1994 Oct; 3(10):1751-6. PubMed ID: 7849697 [TBL] [Abstract][Full Text] [Related]
11. Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia. Hagemann TL; Chen Y; Rosen FS; Kwan SP Hum Mol Genet; 1994 Oct; 3(10):1743-9. PubMed ID: 7880320 [TBL] [Abstract][Full Text] [Related]
12. X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group. Moschese V; Orlandi P; Plebani A; Arvanitidis K; Fiorini M; Speletas M; Mella P; Ritis K; Sideras P; Finocchi A; Livadiotti S; Rossi P Mol Med; 2000 Feb; 6(2):104-13. PubMed ID: 10859027 [TBL] [Abstract][Full Text] [Related]
13. Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: phosphotyrosine-binding and circular dichroism analysis. Mattsson PT; Lappalainen I; Bäckesjö CM; Brockmann E; Laurén S; Vihinen M; Smith CI J Immunol; 2000 Apr; 164(8):4170-7. PubMed ID: 10754312 [TBL] [Abstract][Full Text] [Related]
14. Maternal germinal mosaicism of X-linked agammaglobulinemia. Sakamoto M; Kanegane H; Fujii H; Tsukada S; Miyawaki T; Shinomiya N Am J Med Genet; 2001 Mar; 99(3):234-7. PubMed ID: 11241495 [TBL] [Abstract][Full Text] [Related]
15. X linked agammaglobulinaemia with a 'leaky' phenotype. Jones A; Bradley L; Alterman L; Tarlow M; Thompson R; Kinnon C; Morgan G Arch Dis Child; 1996 Jun; 74(6):548-9. PubMed ID: 8758136 [TBL] [Abstract][Full Text] [Related]
16. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan. Hashimoto S; Tsukada S; Matsushita M; Miyawaki T; Niida Y; Yachie A; Kobayashi S; Iwata T; Hayakawa H; Matsuoka H; Tsuge I; Yamadori T; Kunikata T; Arai S; Yoshizaki K; Taniguchi N; Kishimoto T Blood; 1996 Jul; 88(2):561-73. PubMed ID: 8695804 [TBL] [Abstract][Full Text] [Related]
17. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA. Gaspar HB; Lester T; Levinsky RJ; Kinnon C Clin Exp Immunol; 1998 Feb; 111(2):334-8. PubMed ID: 9486400 [TBL] [Abstract][Full Text] [Related]
18. BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Vihinen M; Belohradsky BH; Haire RN; Holinski-Feder E; Kwan SP; Lappalainen I; Lehväslaiho H; Lester T; Meindl A; Ochs HD; Ollila J; Vorechovsky I; Weiss M; Smith CI Nucleic Acids Res; 1997 Jan; 25(1):166-71. PubMed ID: 9016530 [TBL] [Abstract][Full Text] [Related]
19. Structural basis for X-linked agammaglobulinemia (XLA): mutations at interacting Btk residues R562, W563, and A582. Maniar HS; Vihinen M; Webster AD; Nilsson L; Smith CI Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 2):S198-202. PubMed ID: 7554468 [TBL] [Abstract][Full Text] [Related]
20. Mutations in btk in patients with presumed X-linked agammaglobulinemia. Conley ME; Mathias D; Treadaway J; Minegishi Y; Rohrer J Am J Hum Genet; 1998 May; 62(5):1034-43. PubMed ID: 9545398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]